Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:
| Indexado |
|
||||
| DOI | 10.3389/FNUT.2022.831696 | ||||
| Año | 2022 | ||||
| Tipo | artículo de investigación |
Citas Totales
Autores Afiliación Chile
Instituciones Chile
% Participación
Internacional
Autores
Afiliación Extranjera
Instituciones
Extranjeras
A growing body of evidence indicates that dietary polyphenols could be used as an early intervention to treat glucose-insulin (G-I) dysregulation. However, studies report heterogeneous information, and the targets of the intervention remain largely elusive. In this work, we provide a general methodology to quantify the effects of any given polyphenol-rich food or formulae over glycemic regulation in a patient-wise manner using an Oral Glucose Tolerance Test (OGTT). We use a mathematical model to represent individual OGTT curves as the coordinated action of subsystems, each one described by a parameter with physiological interpretation. Using the parameter values calculated for a cohort of 1198 individuals, we propose a statistical model to calculate the risk of dysglycemia and the coordination among subsystems for each subject, thus providing a continuous and individual health assessment. This method allows identifying individuals at high risk of dysglycemia-which would have been missed with traditional binary diagnostic methods-enabling early nutritional intervention with a polyphenol-supplemented diet where it is most effective and desirable. Besides, the proposed methodology assesses the effectiveness of interventions over time when applied to the OGTT curves of a treated individual. We illustrate the use of this method in a case study to assess the dose-dependent effects of Delphinol (R) on reducing dysglycemia risk and improving the coordination between subsystems. Finally, this strategy enables, on the one hand, the use of low-cost, non-invasive methods in population-scale nutritional studies. On the other hand, it will help practitioners assess the effectiveness of an intervention based on individual vulnerabilities and adapt the treatment to manage dysglycemia and avoid its progression into disease.
| Ord. | Autor | Género | Institución - País |
|---|---|---|---|
| 1 | Olivera-Nappa, Alvaro | Hombre |
Universidad de Chile - Chile
|
| 2 | Contreras, Seba | Hombre |
Max Planck Inst Dynam & Self Org - Alemania
Max Planck Institute for Dynamics and Self-Organization - Alemania |
| 3 | Tevy, Maria Florencia | Mujer |
Universidad de Chile - Chile
|
| 4 | Medina-Ortiz, David | Hombre |
Universidad de Chile - Chile
|
| 5 | Leschot, Andres | Hombre |
Maqui New Life SA - Chile
Maqui New Life S.A - Chile |
| 6 | VIGIL-PORTALES, PILAR | Mujer |
Reprod Hlth Res Inst - Chile
Reproductive Health Research Institute - Chile |
| 7 | CONCA-ROSENDE, CARLOS EUGENIO | Hombre |
Universidad de Chile - Chile
|
| Fuente |
|---|
| CONICYT, Chile |
| Comisión Nacional de Investigación Científica y Tecnológica |
| Fondecyt Project |
| Max-Planck-Gesellschaft |
| Centre for Biotechnology and Bioengineering |
| Max-Planck-Society |
| Centre for Biotechnology and Bioengineering-CeBiB (PIA project, Conicyt, Chile) |
| MNL-Group |
| Agradecimiento |
|---|
| Open Access publication has been enabled by the Max-Planck-Society. SC received support from the Max-Planck-Society. DM-O gratefully acknowledges Conicyt, Chile, for Ph.D. fellowship 21181435. MT gratefully acknowledges Fondecyt Project 1191727. The authors gratefully acknowledge funding from the Centre for Biotechnology and Bioengineering-CeBiB (PIA project FB0001, Conicyt, Chile) and MNL-Group. The authors declare that this study received funding from MNL-Group. This funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. |
| Open Access publication has been enabled by the Max-Planck-Society. SC received support from the Max-Planck-Society. DM-O gratefully acknowledges Conicyt, Chile, for Ph.D. fellowship 21181435. MT gratefully acknowledges Fondecyt Project 1191727. The authors gratefully acknowledge funding from the Centre for Biotechnology and Bioengineering—CeBiB (PIA project FB0001, Conicyt, Chile) and MNL-Group. The authors declare that this study received funding from MNL-Group. This funder was not involved in the study design, collection, analysis, interpretation of data, the writing of this article or the decision to submit it for publication. |